Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12284997 | 0.95 | LMNA (0.59) | LMNAPOLBALDH1A1MGLL | |
| SCHEMBL2908261 | 0.82 | ALDH1A1 (0.46) | LMNAPOLBALDH1A1MGLL | |
| SCHEMBL27761826 | 0.82 | LMNA (0.74) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL1068467 | 0.82 | ALDH1A1 (0.87) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL27825147 | 0.81 | LMNA (0.72) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL14168784 | 0.81 | LMNA (0.43) | LMNAPOLBALDH1A1MGLL | |
| SCHEMBL25323826 | 0.79 | LMNA (0.70) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL18963491 | 0.79 | LMNA (0.70) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL11371705 | 0.79 | LMNA (0.70) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL22170062 | 0.79 | LMNA (0.70) | LMNAPOLBALDH1A1MGLLNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-54076571-A | — | — | None | — | — | JP | disclosed |
| JP-56090871-A | — | — | None | — | — | JP | disclosed |
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2025-10-02 | — | — | US | disclosed |
| CN-115151527-B | Process for the preparation of cyanoacetic esters | 汉高股份有限及两合公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4532465-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2025-04-09 | — | — | EP | disclosed |
| CN-119451941-A | Bio-based cyanoacrylate compounds | 博斯蒂克股份公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2024203772-A1 | METHOD FOR PRODUCING ALPHA-CYANOACRYLATE | 東亞合成株式会社 | 2024-10-03 | — | — | WO | disclosed |
| WO-2023232948-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2023-12-07 | — | — | WO | disclosed |
| EP-4286369-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2023-12-06 | — | — | EP | disclosed |
| CN-115151527-A | Process for the preparation of cyanoacetic esters | 汉高股份有限及两合公司 | 2022-10-04 | — | — | CN | disclosed |
| US-7390595-B2 | Method of preparing a crosslinked polymer in an electrolyte composition | FUJIFILM CORPORATION (JP) | 2008-06-24 | — | — | US | disclosed |
| US-4321180-A | COMPRISING AN ALKYLOXYALKYL 2-CYANOACRYLATE, MOISTURE AND A POLYMERIZATION INHIBITOR | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1982-03-23 | — | — | US | disclosed |
| JP-S5690871-A | ADHESIVE COMPOSITION | TOAGOSEI CHEM IND CO LTD | 1981-07-23 | — | — | JP | disclosed |
| JP-S5476571-A | NOVEL ALPHA-CYANOACRYLATE | TOAGOSEI CHEM IND CO LTD | 1979-06-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BAP1, CBR1, CBR3 | LMNA 992/4885POLB 1279/4885ALDH1A1 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.